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Pulmonary hypertension is an increasingly recognised complication of sarcoidosis that arises from
a variety of physiological mechanisms, including pulmonary ﬁbrosis, granulomatous vasculitis, and
circulating vasoactive mediators. We present the case of a young man with sarcoidosis complicated by
fatal pulmonary hypertension due to extrinsic compression of the major pulmonary vessels by medi-
astinal granulomatous inﬂammation and lymphadenopathy.
 2009 Elsevier Ltd. All rights reserved.A 27-year-old Caucasian male non-smoker presented with 6
years of productive cough, minor haemoptysis, and progressive
dyspnoea. Examination revealed a parasternal heave and loud P2.
Chest radiograph revealed widespread nodular inﬁltrates and
septal thickening. Laboratory investigations were normal except
for elevated serum angiotensin converting enzyme (54 units/L,
12–52). Lung function was abnormal: FEV1 2.27 L (48% pre-
dicted), FVC 4.0 L (66%), TLC 6.69 L (82%), DLCO/VA 88% predicted.
CT angiography showed perihilar conglomerate masses, periph-
eral septal thickening, bronchovascular and clustered nodules
and diffuse increased mediastinal soft tissue consistent with
sarcoidosis. There was encasement and constriction of pulmo-
nary arteries (Fig. 1) and veins (Fig. 2) by this soft tissue. Right
heart catheterisation showed narrowing of middle and distal
pulmonary arteries with focal stenosis of some lobar arteries.
Mean pulmonary artery pressure was 48 mmHg, pulmonary
wedge pressure 10 mmHg, and pulmonary vascular resistance
7.2 Wood units.
The patient was treated with high dose prednisone for several
months without response. He died suddenly at home, while
awaiting assessment for lung transplantation.
The prevalence of pulmonary hypertension (PH) in sarcoid-
osis is below 5%, is more common in severe pulmonary disease,
and confers a poor prognosis.1 Many cases are thought due to
obliteration of vessels by pulmonary ﬁbrosis. Postulated causesn).
rved.of PH without pulmonary ﬁbrosis include granulomatous
vasculitis, occlusive venopathy, or release of vasoactive factors.2
Extrinsic compression of major vessels has been described
in a handful of case reports. In this case we postulate thatFig. 1. CT angiography sequential scan images demonstrating encasement and nar-
rowing of the left lower lobe pulmonary artery by hilar soft tissue (white arrows).
Fig. 2. CT angiography sequential scan images demonstrating constriction of the right
upper lobe pulmonary vein by mediastinal soft tissue (white arrows).
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gressed to ﬁbrosis with entrapment and distortion of medias-
tinal vessels.
Learning points
 In pulmonary hypertension, presence of lobar or segmental
perfusion defects should suggest a disorder of the large vessels
such as extrinsic compression.
 PH in sarcoidosis cannot be assumed to be due to small vessel
involvement by pulmonary ﬁbrosis, even when signiﬁcant
parenchymal disease is seen on CT.Conﬂict of interest
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